Indeed, it has been reported that the BRIP1 and RAD51 pathogenic variants confer at least a 6-fold increased risk for OC [29,33,34], but not for breast cancer, in contrast to the NBN and CHEK2 genes. This evidence concerns the gene CHEK2 and breast carcinoma.